ArticleObesity surgery2026
Long-Term Weight Loss and Metabolic Outcomes After Bariatric Surgery in a Large Asian Cohort: A Real-World Cohort Study.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMetabolic-bariatric surgery (MBS) is the most effective treatment for obesity and its associated metabolic complications. Long-term real-world outcome data from Asian populations remain limited, particularly for procedural comparisons and longitudinal metabolic trajectories.
objectiveTo evaluate weight loss outcomes, metabolic outcomes, and clinical predictors of treatment response following bariatric surgery in a large Asian cohort, with longitudinal follow-up up to five years in a selected subgroup of completers.
methodsThis retrospective cohort study analyzed 1,478 adult patients who underwent primary bariatric surgery (laparoscopic sleeve gastrectomy [LSG], Roux-en-Y gastric bypass [RYGB], or one-anastomosis gastric bypass [OAGB]) between 2012 and 2022 at a single tertiary academic center in Malaysia. The primary outcome was percentage total weight loss (%TWL) at 1, 3, and 5 years, analyzed using an available-case approach. Pre-specified attrition analysis compared the characteristics of 5-year completers with non-completers. Secondary outcomes included longitudinal changes in glycated hemoglobin (HbA1c), blood pressure, and LDL cholesterol, with paired and cross-sectional analyses reported separately. Glycaemic outcome thresholds (HbA1c < 6.5% and < 5.7%) were derived from ADA 2021 criteria; formal remission could not be ascertained because antidiabetic medication data were not available. Procedure-specific 1-year metabolic outcomes were evaluated for LSG and RYGB. Multivariable linear regression explored predictors of 1-year %TWL.
resultsMean %TWL was 20.80 ± 9.71% (n = 917) at 1 year, 25.14 ± 10.30% (n = 349) at 3 years, and 24.52 ± 10.98% (n = 107) at 5 years; the 5-year sample represented 7.2% of the original cohort and was enriched for older patients, those with diabetes and hypertension, and patients with greater 1-year %TWL (25.33% vs. 19.99% in non-completers, p < 0.001), indicating selective retention bias. Among diabetic patients with paired pre-/postoperative HbA1c (n = 35), mean 1-year reduction was 1.01% (p = 0.007); cross-sectional HbA1c among diabetic patients was 5.95 ± 1.08% at 1 year, with 80.9% achieving HbA1c < 6.5% and 47.8% < 5.7%. Significant blood pressure reductions occurred at 1 year in hypertensive patients across both LSG and RYGB subgroups. The regression model was weak (R² = 0.026); pre-existing diabetes (β = -1.83, p = 0.020) and certain non-Malay ethnicity were associated with lower 1-year %TWL as exploratory, hypothesis-generating signals warranting prospective validation. The overall complication rate was 1.7%; OAGB long-term outcomes could not be reliably assessed (5-year n = 3-4).
conclusionsBariatric surgery in this large Malaysian cohort produced significant 1-year weight loss with a favorable safety profile. Three- and five-year data, drawn from a selected subgroup of completers and subject to attrition bias, suggest preserved weight loss in those engaged with follow-up but should not be interpreted as population-level durability claims. Diabetes and ethnicity findings from a weak predictive model are hypothesis-generating and require prospective validation.
Indexed as
Identifiers
42240798What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.